Numb asymmetrically segregates at mitosis to control cell fate choices during development. Numb inheritance specifies progenitor over differentiated cell fates, and, paradoxically, also promotes neuronal differentiation, thus indicating that the role of Numb may change during development. Here we report that Numb nuclear localization is restricted to early thymocyte precursors, whereas timed appearance of pre-T-cell receptor (pre-TCR) and activation of protein kinase Cθ promote phosphorylationdependent Numb nuclear exclusion. Notably, nuclear localization of Numb in early thymocyte precursors favors p53 nuclear stabilization, whereas pre-TCR-dependent Numb nuclear exclusion promotes the p53 downmodulation essential for further differentiation. Accordingly, the persistence of Numb in the nucleus impairs the differentiation and promotes precursor cell death. This study reveals a novel regulatory mechanism for Numb function based on its nucleus-cytosol shuttling, coupling the different roles of Numb with different stages of T-cell development.
Cell fate decision of dividing progenitor-derived cells is a crucial event in development and diseases. Cell fate is often regulated by asymmetric cell division, which is a process by which progenitors asymmetrically segregate certain cell fate determinants during division, to generate two functionally different cells. 1, 2 The adaptor protein Numb was initially identified in Drosophila as a critical cell fate determinant, 3 where loss of Numb and its homolog Numb-like results in the loss of neural progenitors, indicating that the presence of Numb is essential for maintaining the progenitors during the initial progenitor versus neural fate decision. 4, 5 However, re-expression of Numb is also required for further neural differentiation, 6, 7 indicating that the role of Numb in the same tissue may change over time.
Numb function in the immune system has been partially explored. 8, 9 Numb is involved in asymmetric division in hematopoietic stem cells, 10 thymocytes 11 and mature T lymphocytes. 12, 13 T cells develop from intrathymic CD4 − CD8 − double-negative (DN) precursors that, after progression through DN1 (CD44 + CD25 − ), DN2 (CD44 + CD25 + ), DN3 (CD44 − CD25 + ) and DN4 (CD44 − CD25 − ), have to decide between proliferation, to increase the total number of precursors, or differentiation into CD4 + CD8 + double-positive (DP) cells. This decision is made during DN3 stage and appears to be dependent on asymmetric segregation of Numb. 11 As Numb is a well-characterized inhibitor of Notch-1 receptor signaling pathway, 14 the ability of Numb to regulate cell fate decisions during development has been associated with this Numb function. 15 However, the role of Numb during development could not be restricted to the control of Notch-1 signaling, as Numb has been implicated in the regulation of a variety of biochemical pathways, including the tumor suppressor p53. 16 Increasing evidence suggests that p53 regulates cell differentiation in addition to cell proliferation, apoptosis and senescence. 17, 18 Notably, T-cell development is regulated by both Notch-1 and p53. Notch-1 signals appear to be critical for the very early steps of T-cell development (i.e. T-cell commitment). 19 The involvement of p53 has been instead reported in the transition from the DN to the DP stage. However, while the overexpression of p53 during DN3 stage promotes a block in the differentiation and proliferation, resulting in a small thymus size, 20, 21 loss of p53 apparently does not affect thymocyte development, even though the vast majority of spontaneous malignancies in p53 − / − mice are lymphomas. 22 Thus, the double function of Numb could be dependent on two different pathways, which may be differentially triggered during selected differentiation stages.
Recent data describe the presence of Numb in the nuclear compartment, 23 besides its known cytoplasmic localization, raising the possibility that different Numb functions could be regulated by its differential subcellular localization. However, whether Numb may have different subcellular localizations in precursors or more differentiated T cell, how Numb import is regulated or how the nuclear localization affects its function during T-cell development remain unexplored. Here we show that Numb is an important regulator of p53 pathway during T-cell development, and we describe a novel molecular mechanism involved in the differential regulation of Numb-p53 axis based on the regulation of Numb nuclear import, emerging an interesting scenario where Numb can act as a regulator of two fundamental pathways during T-cell development.
Results
Pre-TCR signaling promotes Numb nuclear exclusion. It has been recently shown that Numb localizes in the nucleus of breast cancer cell lines; 23 however, no data about nuclear Numb localization in thymocytes have been reported. We focused our attention on the DN3 stage of thymocyte development, as we previously reported that DN3 development is dependent on Numb function. 11 By confocal microscopy, we examined the subcellular localization of Numb using frozen sections of day 14 fetal thymi, where most of thymocytes are DN cells. We used an anti-pre-T-cell receptor-α chain (pTα) antibody to detect DN3-DN4 cells. As DN1 and DN2 thymocytes do not express pTα, negative cells were considered as DN1-DN2 thymocytes. Nuclear Numb was found only in pTα − cells (DN1-DN2), where Numb was widely distributed in both the cytosol and the nucleus, whereas in pTα-positive cells (DN3-DN4), Numb was preferentially associated with the cell membrane and cytosol showing a nuclear exclusion (Figure 1a ), suggesting that Numb nuclear localization is associated with early stages of T-cell development. Onset of pre-T-cell receptor (pre-TCR) signaling at DN3 stage is a crucial event during T-cell development, which regulates proliferation, differentiation and survival of progenitors. As Numb nuclear exclusion seems to be associated with DN3-DN4 stage, we suggest a key role for pre-TCR signaling in promoting nuclear exclusion of Numb. To test this hypothesis, we used the T-cell receptor-β (TCRβ) chaindeficient cell line SCIET27, lacking pre-TCR, derived from severe-combined immunodeficient (SCID) mouse DN3 thymocytes, 24 and the TCRβ chain stably transfected daughter cell line SCB29, which express a functional pre-TCR. We analyzed the Numb localization by using nuclear and cytosolic fractionation assay. The efficiency of the subcellular fractionation method we used is shown in the Supplementary Figure 1 . Interestingly, in the absence of pre-TCR, Numb was highly expressed in both nucleus and cytosol, whereas in the presence of pre-TCR, Numb appears to be preferentially localized in the cytosol, thus undergoing nuclear exclusion ( Figure 1b ). Consistently, these results were confirmed by the confocal microscopy analysis of Numb subcellular localization performed on the same cells ( Figure 1c ).
Moreover, in thymocytes derived from pTα − / − mice, the absence of pre-TCR signaling results in an exclusive Numb nuclear localization (Figure 1d ), although about 80% of the thymocytes were DN3 (CD25 + CD44 − ). These data were also confirmed by confocal images, which show that CD44 − DN3-DN4 thymocytes from pTα − / − mice display a high Numb nuclear localization ( Figure 1e ). Taken together, the data reported above demonstrate that Numb localizes in the nucleus of early thymocyte precursors and its nuclear localization changes over time, where the appearance of pre-TCR signaling at DN3 stage promotes nuclear exclusion.
Pre-TCR signaling regulates PKCθ-mediated Numb phosphorylation. Phosphorylation status has been shown to regulate nuclear localization signal (NLS)-dependent nuclear import. 25 Interestingly, atypical protein kinase C (aPKC)mediated Numb phosphorylation has been described to regulate Numb subcellular localization and membrane polarization, 26 influencing Numb function in neural 27, 28 and epithelial cells. 29 The role of aPKC is not conserved in lymphocytes, 30 whereas PKCθ has been shown to have key roles in T-cell activation and proliferation. 31 Thus, we wanted to first analyze whether PKCθ is able to phosphorylate Numb. Human embryonic kidney 293 (HEK293) cells were cotransfected with Flag-Numb p66-expressing vector with or without a constitutively active mutant of PKCθ (CA-PKCθ). Immunoprecipitation of Flag-Numb p66 immunoblotted with a specific antibody, named anti-P-serine PKC (anti-P-ser PKC) substrate, which recognizes only the serine residues of substrate proteins phosphorylated by PKC kinases, 32 shows that Numb p66 displays an increase in serine phosphorylation levels in the presence of CA-PKCθ ( Figure 2a ). As PKCθ activity is regulated by pre-TCR signaling, 33 we next sought to determine whether Numb phosphorylation is influenced by the presence of pre-TCR. Using an antibody that recognizes the PKCθ phospho-threonine 538 (Thr538), which is phosphorylated only when PKCθ is activated, 34 we found increased PKCθ activation in pre-TCR-competent SCB29 cells when compared with pre-TCR-deficient SCIET27 cells (Figure 2b , left panel). Accordingly, immunoprecipitation of endogenous Numb in SCB29 and SCIET27 cells shows an increment of phospho-serine-Numb in the presence of a functional pre-TCR ( Figure 2b , right panel). To discard a redundant role between PKC isozymes expressed in thymocytes, we used Rottlerin, a compound that specifically inhibits PKCθ activity in T cells when it is used at a low concentration (3 uM). 35 The phospho-Numb levels decreased in Rottlerin-treated SCB29 pre-TCR-competent cells when compared with cells treated with the vehicle alone ( Figure 2c , left panel). The specificity of Rottlerin treatment was confirmed using the anti-P-PKCθ Thr538 antibody, which shows decreased PKCθ activity after treatment (Figure 2c , left panel). Conversely, in the absence of pre-TCR, the treatment with phorbol ester (phorbol-12-myristate-13-acetate (PMA)), a potent activator of PKC in eukaryotic cells, promotes an increase of phospho-Numb levels that correlates with an increase of the PKCθ activity 33 (Figure 2d ). Consistently, thymocytes from pTα − / − mice showed low basal phosphorylation levels of Numb that were increased in the presence of PMA (Figure 2e ). Taken together, our data demonstrate that Numb is a novel substrate of PKCθ in T-cell context and its phosphorylation is under the regulation of pre-TCR signaling.
Phosphorylation regulates Numb nuclear import. We then investigated the presence of NLS in Numb protein by using the program PSORT II. We identified two putative NLS sequences, both located in the N-terminal region of the protein including part of the phosphotyrosine-binding domain (PTB) domain ( Supplementary Figure 2a ). To determine the contribution of these putative NLS sequences to the nuclear import of Numb, we analyzed the ability of different Numb mutants to migrate into the nucleus (Figure 3a ). Mutants containing the N-terminal region of the PTB domain were able to localize in the nucleus, whereas the truncation mutant lacking the N-terminal region (Numb-ΔN mutant), in which we deleted both the NLS sequences predicted by PSORT II, was defective in nuclear importing (Figure 3a , lower panel). Interestingly, we found a putative PKC-dependent phosphorylation site adjacent to the NLS at ninth position ( Supplementary Figure 2b) , raising the possibility that the subcellular localization of Numb is dependent on PKCθmediated phosphorylation. By confocal microscopy analysis, we analyzed the subcellular localization pattern of Numb transfected in HEK293 cells in the presence or absence of Figure 3b , the co-transfection of CA-PKCθ results in a marked increase of cytosolic Numb and a decrease of nuclear Numb.
Confirming the above data, the inhibition of PKCθ by Rottlerin in a pre-TCR-competent context resulted in a change of Numb localization, promoting nuclear Numb accumulation ( Figure 3c ). Accordingly, an opposite effect was observed when PKCθ activity was mimicked in the absence of pre-TCR, by using PMA: while cytosolic Numb levels increase, nuclear Numb levels decrease markedly after PMA treatment of pre-TCR negative SCIET27 cells ( Figure 3d ). Consistently, the above results were also confirmed by confocal analysis (Figure 3e ). Taken together, these data suggest that PKCθmediated Numb phosphorylation, once pre-TCR signaling is triggered at DN3 stage, results in the subcellular redistribution of Numb, promoting its nuclear exclusion.
Numb nuclear localization is essential for p53 stabilization. It has been shown that Numb promotes p53 stabilization blocking the function of the mouse double minute 2 (Mdm2) E3-ubiquitin ligase and, interestingly, both p53 and Mdm2 are hosted in the nucleus. 36 Western blot analysis in SCB29 and SCIET27 cells revealed that Numb nuclear levels were correlated with p53 levels, resulting in increased nuclear p53 and its target p21 in SCIET27 cells, in which we observe nuclear Numb, when compared with SCB29 cells, displaying Numb nuclear exclusion ( Figure 4a ). Moreover, treatment of SCIET27 cells with PMA, which activates PKCθ and decreases Numb nuclear levels, was also able to promote a decline in p53 level in the nucleus (Figure 4b ). Notably, Numb total levels increased after PMA treatment, suggesting that p53 stabilization was dependent on nuclear Numb levels but not on total Numb levels ( Figure 4b , right panel). Accordingly, similar results were obtained in thymocytes derived from pTα − / − mice (Figure 4c ). Next, we analyzed p53 stability under different Numb localization conditions. Figure 4d shows that overexpression of Numb in HEK293 cells disrupts p53-Mdm2 interaction, resulting in a decrease of p53 polyand monoubiquitination after treatment with the proteasome inhibitor MG132 (Figure 4e ). In contrast, we observed that upon Numb nuclear exclusion conditions, p53 does not undergo stabilization. First, when ΔN-Numb mutant, which shows nuclear exclusion (Figure 3a) , was expressed, Mdm2-p53 interaction and p53 ubiquitination were comparable with that observed in the absence of ΔN-Numb (Figures 4f and g) , although ΔN mutant maintained the ability to bind to Mdm2 and to be degraded as the WT Numb ( Supplementary Figures 3a and b) . Second, coexpression of Figure  3c , lanes 3 and 4) was able to stabilize p53 protein, resulting in the same degradation rate than in the absence of Numb (Supplementary Figure 3c, lane 1) , whereas in the presence of overexpressed WT Numb alone (Supplementary Figure 3c , lane 2), p53 was completely stabilized, as expected. Taken together, these results show that Numb nuclear import is essential for Numb-mediated p53 stabilization. Notably, Numb PTB peptides have been used to block Mdm2 function and consequently to stabilize p53-mimicking Numb function. 37 We confirm here that Numb PTB mutant retains the ability to interact with Mdm2 ( Supplementary  Figure 4a ). In addition, overexpression of Numb PTB was able to stabilize p53, by decreasing its ubiquitination in comparable manner, with respect to WT Numb overexpression (Figure 4j ). Interestingly, Numb PTB nuclear localization was independent of PKCθ activity, as CA-PKCθ did not affect the subcellular localization pattern of PTB mutant ( Supplementary Figure 4b) . Taken together, these data show that Numb nuclear function is dependent on the PTB domain. Moreover, Numb PTB nuclear localization appears not to be regulated by PKCθ, possibly because of its small size (18 kDa), which may allow the cross of nuclear membrane by diffusion. 38 Nuclear localization of Numb promotes its own proteosomal degradation. As the turnover of Numb, similar to p53, is also regulated by Mdm2, 37 one likely cause of increase in Numb total levels in the presence of activated PKC after PMA treatment, which increases cytosolic levels of Numb ( Figures  4b and c) , is that the half-life of Numb could be coupled with its nuclear localization, being dependent on its interaction with Mdm2.
However, nuclear Numb degradation has not been reported before. To address this issue, we compared Numb half-life in SCB29 and SCIET27 cells, in which Numb display a differential subcellular localization pattern. Our analysis revealed a correspondence between the localization and the degradation rate of Numb. Indeed, SCB29 cells, where Numb was cytosolic, displayed a higher Numb stability, whereas in SCIET27 cells, where Numb was localized in the nucleus, Numb was rapidly degraded (Figure 5a ). Pharmacologic treatments, which decrease or increase PKCθ activity, changed Numb localization pattern and impact in the half-life of Numb; when SCB29 cells were treated with Rottlerin in the presence of CHX, there was a significant decline in the half-life of Numb protein (Figure 5b) . Interestingly, longer exposition to Rottlerin markedly decreased both cytosolic and nuclear levels of Numb in SCB29 cells and this effect was reversed in the presence of MG132, which revealed a Numb accumulation in the nuclear compartment (Figure 5c) , showing that the downmodulation of Numb is because of its nuclear proteosomal degradation. The opposite effect was observed in SCIET27 cells treated with PMA, where the half-life of Numb displayed an increase (Figure 5d ).
Enforced Numb nuclear function during DN3 stage inhibits T-cell precursors' differentiation. Next, we analyzed the localization of Numb during DN3 stage, after a fluorescent-activated cell sorting of total DN thymocytes derived from WT Numb, transgenic mice overexpressing fulllength Numb (Numb TG) and transgenic mice overexpressing the myc-tagged Numb PTB domain (Numb PTB TG). 11 As DN1-DN2 thymocytes are CD44 positives and DN3-DN4 are CD44 negatives, we performed a CD44 staining of isolated DN cells to discriminate between these sub-populations. Confocal images revealed that overexpression of full-length Numb in Numb TG did not affect the subcellular localization of Numb at DN3 stage (CD44 − cells) when compared with WT thymocytes, maintaining the nuclear exclusion at this stage. Conversely, Numb PTB retained the ability to localize in the nucleus during DN3 stage despite the presence of pre-TCR, confirming our results above (Figure 6a) , and it was comparable to that one of full-length Numb in thymocytes from pTα − / − mice, being mostly nuclear (Figure 6a) . These data were also confirmed by using nuclear-cytosol fractionated extracts from total thymocytes derived from the same mice (Figure 6b ). We further analyzed the thymus phenotype of different mutant mice. Interestingly, phenotype analysis of thymocytes from Numb PTB transgenic and pTα − / − mice revealed a correlation between the presence of Numb or Numb PTB in the nucleus at DN3 stage and the increased percentage in CD25 + CD44 − DN3 cells and decreased percentage of CD25 − CD44 − DN4 cells, suggesting a block in T-cell differentiation at DN3 stage. Conversely, nuclear exclusion of Numb at DN3 stage in WT and Numb TG mice correlated with the predicted normal T-cell development and differentiation observed in these mice (Figure 6c ). In keeping with this, we observed that while overexpression of WT Numb in Numb TG thymocytes does not alter the expression levels of p53 and p21, when compared with wild-type thymocytes, overexpression of Numb PTB instead increased both p53 and p21 nuclear levels in thymocytes (Figure 6d) , similar to what we observed in pre-TCR loss conditions. Moreover, the increased p53 and p21 levels observed correlate with an increased cell death by apoptosis of DN3 cells measured by Annexin V staining (Figure 6e ). Therefore, inhibition of Numb nuclear function mediated by pre-TCR signaling appears to be essential during DN3 stage to promote proper thymocytes survival and differentiation.
Discussion
During development, Numb exerts two different roles that may seem opposite, as it maintains progenitor fate and promotes cell differentiation. 6 This makes it difficult to understand which pathways are regulated by Numb and raises the possibility that these different roles are mediated by diverse Numb functions. In this report, we demonstrate that Numb extends its capacity to the regulation of p53 function during T-cell development. Our data provide evidence for a model, where the different subcellular localization patterns of Numb may reciprocally regulate p53 and its own stability. In this model, the presence and function of pre-TCR signaling at DN3 stage, by promoting the nuclear exclusion of Numb, is responsible of the p53 downmodulation, necessary to allow the survival of DN3 thymocytes, and thus to continue their differentiation (Figure 7 ). This is in agreement with previous reports where p53 downmodulation has been suggested to be a pre-TCR triggering downstream event. 20, 21 Notably, loss of pre-TCR signaling in SCID, RAG − / − and CD3γ − / − mice 21 promotes a block of thymocyte differentiation at DN3 stage, associated with an increase of p53 levels. In keeping with this, our data show that the absence of pre-TCR signaling in thymocytes from pTα − / − mice promotes a nuclear Numb accumulation at DN3 stage, which result in high levels of p53, a block at DN3 stage, an increase in cell death by apoptosis, and consequently a small thymus size. Interestingly, Numb PTB TG mice, where nuclear Numb function is maintained during DN3 stage, show a similar phenotype. Notably, Mdm 2 puro/Δ7 − 12 mice, 39 where the level of Mdm2 expression is decreased, show an increment of p53 levels associated with a block of thymocyte differentiation similar to that one observed in Numb PTB TG mice. Moreover, high levels of p53 expression are observed in thymocytes of embryonic thymus from E14.5 to E16.5. 40 Notably, we show that the high levels of p53 expression in the thymus of E14.5 mice correlate with the presence of nuclear Numb in such age thymus. All these data suggest that Numb nuclear function during T-cell development is finely regulated by its localization. However, it appears to be independent of total Numb levels as we observed that overexpression of Numb in Numb TG mice does not affect its nuclear function. This is also in agreement with previous data where overexpression of Numb does not influence cell survival. 41 Our findings suggest that the main role of Numb in T-cell development could be focused on p53 regulation. In this scenario, the absence of Numb is expected to impair p53 stabilization but not to alter T-cell specification, as previous data have shown, 9 as loss of p53 apparently does not affect thymocyte development. 22 Data from other cell systems in which Numb function has been studied in detail reveal that the dual role of Numb is regulated based on its interaction with ACBD3, a Golgiassociated protein. 7 ACBD3 has been described to hold its targets within cytosol during mitosis, by inhibiting their translocation into the nucleus. 42 Moreover, Numb AB domain is responsible of Numb-ACBD3 interaction. Notably, we show here that the NLS of Numb is hosted in this domain, thus raising the interesting possibility that cytosolic ACBD3 may impinge on Numb nuclear translocation, finally inhibiting p53 activity and consequently promoting a change in Numb function over time. Taken together, these observations allow us to hypothesize that a similar mechanism may be active during thymocyte differentiation, although the ACBD3 expression has not been reported in lymphocytes, as yet. Notably, Igl mutant brains show an increase in cortical aPKC activity, resulting in the deregulation of Numb phosphorylation. Under these conditions, neuroblasts are not able to complete the differentiation process. 27 Interestingly, the phenotype exhibited by Igl mutant is remarkably similar to that observed in ACBD3 mutants, in which inhibition of nuclear function of Numb may be responsible of an altered differentiation.
Overall, our data reveal important keys in the Numb function regulation, where Numb function is exquisitely regulated through its own subcellular distribution to balance alternative pathways at different stages of development.
Materials and Methods
Mice. pTα − / − , 43 Numb TG and Numb PTB TG mice 11 Immunofluorescence and confocal microscopy. Fetal thymi were fixed with 4% paraformaldehyde solution in PBS, treated with 20% sucrose solution in PBS, immersed in OCT (Tissue Tek) and frozen with a mixture of 2-methylbutene and dry ice. Sections (10 μm) were fixed, permeabilized with Triton X-100, blocked in a solution containing 5% normal goat serum and 3% of bovine serum albumin and stained in the same solution. Sections were mounted with ProLong Antifade (Molecular Probes, Life Technologies Corporation, Carlsbad, CA, USA). Antibodies used were as follows: anti-numb (Cell Signaling, Beverly, MA, USA), anti-CD44 Alexa-647 conjugated, anti-pTα (BD Bioscience), biotinylated anti-myc (Upstate Biotechnology) and DAPI. We use a Leica TCS SP5 confocal microscope with either x20 or x40 objective; images were collected at 8-bit depth, with a resolution of 1024 × 1024 pixels. Images were processed using LAS AF (Leica Microsystems) and Adobe Photoshop software (Adobe Systems, San Jose, CA, USA). The software LAS AF (Leica Microsystem) was used to quantify fluorescent images. Inside each cell, one gate for the nucleus, using DAPI as a marker, and one gate for the cytosol was drawn and threshold intensities of total pixels were determined for Numb.
Plasmids and cell transfection. Transient transfection experiments were performed by TransFectin Lipid Reagent (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. The expression vectors for CA-PKCθ, 44 Flag-WT Numb and Flag-Numb mutant, 45 Myc-PTB Numb (provided by M Canelles), Flag-p53, Mdm2 and HA-ubiquitin have been described elsewhere.
Cells lines and treatments. HEK293 cells were used for transient transfection experiments. SCIET27 (TCRβ-deficient) and SCB29 (TCRβ-transfected) cells 24 were described previously. In similar cases, cells were treated with different compounds. Thirty micromolar proteasome inhibitor MG132, 3 μM PKCθ inhibitor Rottlerin (Calbiochem, Darmstadt, Germany), 10 μg/ml ribosome inhibitor CHX (Sigma-Aldrich, St. Louis, MO, USA), 7.5 ng/ml nuclear export inhibitor leptomycin B (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 50 ng/ml PKC activator PMA (Sigma-Aldrich) for the times indicated.
Protein extracts, immunoprecipitation and immunoblotting. Total extracts and immunoprecipitations were performed as described previously. 33 For immunoblotting, proteins were resolved by SDS-PAGE and blotted into the nitrocellulose membrane. The blots were incubated with the following antibodies: anti-β-actin, anti-HA, anti-myc and anti-flag were from Sigma-Aldrich; anti-tubulin, anti-p53, anti-p21, anti-Mdm2 and anti-laminB were from Santa Cruz Biotechnology; and anti-numb, anti-phospho-PKCθ (Thr538) and anti-P-ser PKC substrate were from Cell Signaling. Subcellular fractionation. Cells were resuspended in ice-cold hypotonic buffer (10 mM KCl, 10 mM HEPES (pH 7.4), 10 mM NaCl, 0.1 mM EDTA, 1 mM DTT and 0.5 mM PMSF) and incubated on ice for 15 min. A measure of 0.6% NP-40 was added and lysates were vortexed for 10 s. The lysates were centrifuged at 12 000 r.p.m. for 1 min to remove nuclei and cell debris, and the supernatant (cytosol) was collected and centrifuged at 12 000 r.p.m. for 30 min at 4°C. The pellet was resuspended in hypotonic buffer with 0.6% of NP-40 and vortexed and washed three times at 12 000 r.p.m. for 2 min at 4°C. The pellet was resuspended in the buffer (0.4 M NaCl, 20 mM HEPES (pH 7.4), 1 mM EDTA, 1 mM DTT and 1 mM PMSF) and incubated on ice for 30 min. The lysates were centrifuged at 12 000 r.p. m. for 30 min and the supernatant (nucleus) was collected. 
